Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms

Journal of Cellular Biochemistry

Volumn 112, Issue 10, 2011, Pages 2882-2890

  Cao, Meng Meng ^a,b   Xu, Wang Xiang ^b   Li, Chang Yan ^b,c   Cao, Chuan Zeng ^b   Wang, Zhi Dong ^b   Yao, Jia Wei ^a,b   Yu, Miao ^b   Zhan, Yi Qun ^b   Wang, Xiao Hui ^b   Tang, Liu Jun ^b   Chen, Hui ^b   Li, Wei ^b   Ge, Chang Hui ^b,c   Yang, Xiao Ming ^a,b,c  

^a TIANJIN UNIVERSITY   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c State Key Laboratory of Proteomics   (China)

Author keywords

autocrine; HCC; hepassocin; intracrine

Indexed keywords

HEPASSOCIN; MITOGENIC AGENT; NEUTRALIZING ANTIBODY; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOCRINE EFFECT; CARCINOMA CELL; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTIBODIES, NEUTRALIZING; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; SIGNAL TRANSDUCTION;

EID: 80053212592     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23202     Document Type: Article

References (26)

1. Alberti L, Thomachot MC, Bachelot T, Menetrier Caux C, Puisieux I, Blay JY,. 2004. IL-6 as an intracrine growth factor for renal carcinoma cell lines. Int J Cancer 111: 653-661. (Pubitemid 39062886)
2. Braun-Dullaeus RC, Mann MJ, Dzau VJ,. 1998. Cell cycle progression: New therapeutic target for vascular proliferative disease. Circulation 98: 82-89. (Pubitemid 28312083)
3. Cayrol C, Knibiehler M, Ducommun B,. 1998. p21 Binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16 (3): 311-320. (Pubitemid 28052285)
4. Denicourt C, Dowdy SF,. 2004. Cip/Kip proteins: More than just CDKs inhibitors. Genes Dev 18: 851-855. (Pubitemid 38529654)
5. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP,. 1989. Autocrine interaction between TGF alpha and the EGF-receptor: Quantitative requirements for induction of the malignant phenotype. Oncogene 4: 831-838. (Pubitemid 19176969)
6. Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson Weller A,. 2000. Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med 192: 1797-1808.
7. Hara H, Yoshimura H, Uchida S, Toyoda Y, Aoki M, Sakai Y, Morimoto S, Shiokawa K,. 2001. Molecular cloning and functional expression analysis of a cDNA for human hepassocin, a liver-specific protein with hepatocyte mitogenic activity. Biochim Biophys Acta 1520: 45-53. (Pubitemid 32721933)
8. Hara H, Uchida S, Yoshimura H, Aoki M, Toyoda Y, Sakai Y, Morimoto S, Fukamachi H, Shiokawa K, Hanada K,. 2000. Isolation and characterization of a novel liver-specific gene, hepassocin, upregulated during liver regeneration. Biochim Biophys Acta 1492: 31-44. (Pubitemid 30349178)
9. Jeffers M, Rong S, Anver M, Vande Woude GF,. 1996. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. Oncogene 13: 853-856.
10. Kakazu A, Chandrasekher G, Bazan HP,. 2004. HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad but not the ERK1/2-mediated signaling pathway. Invest Ophthalmol Vis Sci 45: 3485-3492. (Pubitemid 39298566)
11. Kan M, Huang J, Mansson PE, Yasumitsu H, Carr B, Mckeehan WL,. 1989. Heparin-binding growth factor type 1 (acidic fbroblast growth factor): A potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc Natl Acad Sci USA 86: 7432-7436. (Pubitemid 19254470)
12. Keating MT, Willianms LT,. 1988. Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science 239: 914-916. (Pubitemid 18065433)
13. Levy Y, Tsapis A, Brouet JC,. 1991. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines. J Clin Invest 88: 696-699.
14. Li CY, Cao CZ, Xu WX, Cao MM, Yang F, Lan D, Yu M, Zhan YQ, Gao YB, Li W, Wang ZD, Ge CH, Wang QM, Peng RY, Yang XM,. 2010. Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure. Gut 59: 817-826.
15. Mange B, Chrina S, Henrik WH, Anders W, Anders S,. 1999. The role of hepatocyte growth factor and its receptor C-Met in multiple myeloma and other blood malignancies. Leuk Lymphoma 32: 249-256.
16. Mead JE, Faust N,. 1989. Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 86: 1558-1562. (Pubitemid 19078942)
17. Mochida S, Ishikawa K, Inao M, Shibuya M, Fujiwara K,. 1996. Increased expression of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver. Biochem Biophys Res Commun 226: 176-179. (Pubitemid 26332182)
18. Pech N, Hermine O, Goldwasser E,. 1993. Further study of internal autocrine regulation of multipotent hematopoietic cells. Blood 82: 1502-1506. (Pubitemid 23263966)
19. Re RN, Cook JL,. 2006. The intracrine hypothesis: An update. Regul Pept 133 (1-3): 1-9. (Pubitemid 41820328)
20. Skov Oslen P, Boesby S, Kirkegaard P, Therkelsen K, Almdal T, Poulsen SS, Nexø E,. 1988. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 8: 992-996.
21. Thomas JE, Massalski PR, Harrison BD,. 1986. Production of monoclonal antibodies to African cassava mosaic virus and differences in their reactivities with other Whitefly-transmitted Geminiviruses. J Gen Virol 67: 2739-2748.
22. Toyoshima H, Hunter T,. 1994. p27, A novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78 (1): 67-74. (Pubitemid 24228301)
23. Westermark B, Heldin CH,. 1991. Platelet-derived growth factor in autocrine transformation. Cancer Res 51: 5087-5092.
24. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D,. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704. (Pubitemid 24036020)
25. Yan J, Yu Y, Wang N, Chang Y, Ying H, Liu W, He J, Li SQ, Jiang WL, Li YL, Liu HM, Wang HY, Xu YH,. 2004. LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma. Oncogene 23: 1939-1949. (Pubitemid 38445420)
26. Yu HT, Yu M, Li CY, Zhan YQ, Xu WX, Li YH, Li W, Wang ZD, Ge CH, Yang XM,. 2009. Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of HNF1alpha with decreased levels of hepassocin in human hepatocellular carcinoma. J Biol Chem 284: 13335-13347.